Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - TOTAL EQUITY
Total Equity NVO - Novo Nordisk A/S
107 B
LAST VALUE
22.73%
2 YEAR CAGR
15.50%
5 YEAR CAGR
9.61%
10 YEAR CAGR